Press release
Global Quinolones Market Comprehensive Study: Forecasted Market Size And Growth Rate | Bayer AG, Novartis AG, Sanofi SA, Johnson & Johnson Services Inc., Merck & Co. Inc., LG Life Sciences, Allergan Inc., Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Ph
Quinolones Market Size
The Business Research Company offers in-depth market insights through Quinolones Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The quinolones market size has grown steadily in recent years. It will grow from $48.31 billion in 2023 to $50.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to antibiotic demand and usage, regulatory approvals, research and development, competitive landscape, patent expirations.
The quinolones market size is expected to see steady growth in the next few years. It will grow to $61.51 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to emerging diseases, regulatory changes, global health policies:, rising antibiotic resistance, market expansion strategies. Major trends in the forecast period include .
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp
Market Segmentation:
The quinolones market covered in this report is segmented -
1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types
2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Major Driver - Quinolones Market Surge Is A Strategic Response To Escalating Incidence Of Infectious Diseases
The rise in the incidence of infectious diseases is significantly contributing to the growth of the quinolones market. Infectious diseases refer to illnesses brought on by microbes such as parasites, fungi, bacteria, and viruses. Quinolones are widely used for treating a variety of infectious diseases caused by bacteria such as tuberculosis and urinary tract infections. For instance, according to 2022 data released by the Pan American Health Organization, a US-based international public health agency working to improve the health and living standards of the people of the Americas, approximately 10.6 million people fell ill with tuberculosis (TB) in 2021, an increase of 4.5%. Therefore, the rise in the incidence of infectious diseases will drive the quinolones market.
Competitive Landscape:
Major companies operating in the quinolones market report are Bayer AG, Novartis AG, Sanofi SA, Johnson & Johnson Services Inc., Merck & Co. Inc., LG Life Sciences, Allergan Inc., Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, Bausch Health Companies Inc., KYORIN Holdings Inc., MerLion Pharmaceuticals GmbH, Teva Pharmaceutical Industries Ltd., GSK plc, AbbVie Inc., Zee Laboratories, Cipla Ltd., Bhavishya Pharmaceuticals, Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Mylan N.V., Wockhardt Ltd. .
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report
Top Trend - Pinnacle Role Of Product Innovation In The Dynamic Quinolones Market
Product innovation is the key trend gaining popularity in the quinolones market. Major companies operating in the quinolones market are focusing on developing innovative products to sustain their market position. For instance, in January 2023, the South Korean branch of Viatris, a US-based pharmaceutical company launched Dovprela, a new drug-resistant tuberculosis treatment. Dovprela is a three-drug regimen of bedaquiline, pretomanid, and linezolid (BPaL) for treating adult patients with extensively drug-resistant TB and treatment-resistant or non-responsive multidrug-resistant TB. Dovprela reduces the treatment period from 18-20 months to 5-6 months due to its rapid anti-tuberculosis effect.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Quinolones Market Characteristics
3. Quinolones Market Trends And Strategies
4. Quinolones Market - Macro Economic Scenario
5. Quinolones Market Size And Growth
…..
27. Quinolones Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Quinolones Market Comprehensive Study: Forecasted Market Size And Growth Rate | Bayer AG, Novartis AG, Sanofi SA, Johnson & Johnson Services Inc., Merck & Co. Inc., LG Life Sciences, Allergan Inc., Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Ph here
News-ID: 3426259 • Views: …
More Releases from The Buisness Research Company
Organic Period Care Products Market Anticipated To Witness Robust Growth, Surpas …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Current Organic Period Care Products Market Size and Its Estimated Growth Rate?
The size of the market for organic period care products has significantly expanded in recent years, and it's projected to escalate from $2.63 billion in 2024 to $2.83 billion in 2025, with a compound annual growth rate…
Porous Ceramics Market 2024: Trends, Industry Insights, and Growth Drivers
The Business Research Company recently released a comprehensive report on the Global Porous Ceramics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
AI in Automotive & Transportation Market 2024: Key Trends and Growth Outlook
The Business Research Company recently released a comprehensive report on the Global AI In Automotive And Transportation Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The …
Anosmia Global Market 2024 Strategic Outlook Emerging Trends and Market Forecast
The new report published by The Business Research Company, titled Anosmia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the anosmia market size has grown strongly in recent years. It will grow from $3.24 billion in 2023 to $3.55…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
